TSI Releases OmniWear Noise™ – Lightweight, Easy-to-Use Dosimeter

Noise monitoring

 TSI Releases OmniWear Noise™ – Lightweight, Easy-to-Use Dosimeter

05 Sep, 2025

TSI Incorporated has launched the OmniWear Noise™ Dosimeter, a compact, 36g wearable device designed to simplify workplace noise monitoring. Despite its small size, it delivers accurate, real-time data across all workplace noise parameters, helping employers assess exposure risks effectively.

Occupational noise contributes to around 16% of hearing loss worldwide, according to the WHO. Wearable dosimeters like OmniWear Noise™ allow dynamic, shift-long monitoring to identify when and where exposure risks occur.

With one-button operation, rugged design and a 16-hour battery life, the dosimeter is built for easy deployment across various industries. Even first-time users can quickly gather and report data for compliance or task-specific assessments.

The companion app, available on Apple and Android, connects via Bluetooth to up to 20 dosimeters simultaneously. It provides real-time monitoring, exposure averages over an 8-hour shift, and post-run reporting - allowing employers to take timely action to reduce hearing risk.

Ketan Mehta, VP of Global Sales & Marketing, said: “OmniWear Noise™ is ideal for safety professionals new to dosimetry - intuitive, robust, and accurate. Combined with the app, it offers a low-burden solution to capture essential noise data.

For additional information, please contact Casella.

Latest News

IET 36.3 May

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
Bacterial biofilms eject cells like ‘escape pods’ in survival strategy
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
UK refining capacity falls to four plants after a second unplanned closure
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow